Back
ESC Premium Access

Prevalence of left atrial enlargement in patients undergoing an echocardiogram for cardiovascular risk stratification at an esh excellence centre in italy

Session: Poster Session 6 - Hypertension mediated target organ damage and hypertension phenotypes
Topic: Target Organ Damage/Left Ventricular Hypertrophy
Speaker: Professor M. Muiesan (Brescia, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Maria Lorenza Muiesan

University of Brescia, Brescia (Italy)
9 presentations
0 follower

13 more presentations in this session

The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients

Speaker: Doctor A. Farcas (Cluj Napoca, RO)

Access
Abstract
Like
Thumbnail

Assessment of carotid cross sectional area in hypertensive patients: phenotyping and prognostic validation in the campania salute network

Speaker: Doctor C. Mancusi (Napoly, IT)

Access
Abstract
Like
Thumbnail

High level of the amount of ECG peaks SV1+RV5-V6 predict new cases of hypertension in the organized population of the petrochemical industry workers

Speaker: Doctor A. Ukla (Gomel, BY)

Access
Like
Thumbnail

Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: Data from a 8-year-follow-up study

Speaker: Doctor I. Leontsinis (Athens, GR)

Access
Abstract
Like
Thumbnail

Left atrial dysfunction is a potent predictor of ischemic complications in hypertensive patients

Speaker: Associate Professor D. Shorikova (Chernivtsi, UA)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 6 - Hypertension mediated target organ damage and hypertension phenotypes

Speakers: Professor M. Muiesan, Doctor A. Farcas, Doctor C. Mancusi, Doctor A. Ukla, Doctor I. Leontsinis...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources